Involvement of substance P and the NK-1 receptor in human pathology.
The peptide substance P (SP) shows a widespread distribution in both the central and peripheral nervous systems, but it is also present in cells not belonging to the nervous system (immune cells, liver, lung, placenta, etc.). SP is located in all body fluids, such as blood, cerebrospinal fluid, breast milk, etc. i.e. it is ubiquitous in human body. After binding to the neurokinin-1 (NK-1) receptor, SP regulates many pathophysiological functions in the central nervous system, such as emotional behavior, stress, depression, anxiety, emesis, vomiting, migraine, alcohol addiction, seizures and neurodegeneration. SP has been also implicated in pain, inflammation, hepatitis, hepatotoxicity, cholestasis, pruritus, myocarditis, bronchiolitis, abortus, bacteria and viral infection (e.g., HIV infection) and it plays an important role in cancer (e.g., tumor cell proliferation, antiapoptotic effects in tumor cells, angiogenesis, migration of tumor cells for invasion, infiltration and metastasis). This means that the SP/NK-1 receptor system is involved in the molecular bases of many human pathologies. Thus, knowledge of this system is the key for a better understanding and hence a better management of many human diseases. In this review, we update the involvement of the SP/NK-1 receptor system in the physiopathology of the above-mentioned pathologies and we suggest valuable future therapeutic interventions involving the use of NK-1 receptor antagonists, particularly in the treatment of emesis, depression, cancer, neural degeneration, inflammatory bowel disease, viral infection and pruritus, in which that system is upregulated.
Research Laboratory on Neuropeptides (IBIS), Virgen del Rocío University Hospital, Sevilla, Spain, mmunoz@cica.es.
Miguel
M
Muñoz
Rafael
R
Coveñas
D000437:Alcoholism / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001424:Bacterial Infections / Q000378:metabolism*; D003863:Depression / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D008881:Migraine Disorders / Q000378:metabolism; D009369:Neoplasms / Q000378:metabolism*; D010146:Pain / Q000378:metabolism; D018040:Receptors, Neurokinin-1 / Q000502:physiology*; D012640:Seizures / Q000378:metabolism; D013315:Stress, Psychological / Q000378:metabolism; D013373:Substance P / Q000502:physiology*; D014777:Virus Diseases / Q000378:metabolism*; D014839:Vomiting / Q000378:metabolism* / Q000503:physiopathology
D018040:Receptors, Neurokinin-1; D013373:Substance P